2014PubMedRequires access

[Roles of p53 in the interaction of p21 and cell cycle proteins induced by benzo [a] pyrene].

Xia'nan Zhang, Yuegang Li, Xiaowei Jia, Bingci Liu, Meng Ye

Open publisher page 1 citations

Abstract

OBJECTIVE: To investigate the roles of p53 in the interaction of p21, cyclin D1 and CDK4 in human embryonic lung fibroblasts (HELFs) induced by benzo (a) pyrene. METHODS: p53-H group (cells transfected with p53 small interference RNA plasmid, p53 siRNA) and HELF/CMV group (cells transfected with CMV vector) were treated with 2 micromol/L B [a] P for 24 h, and HELF/CMV + PFT-alpha group (HELF/CMV cells were treated with p53 chemical inhibitor, Pifithrin-alpha) was treated with 2 micromol/L B [a] P and 20 micromol/L PFT-alpha for 24 h. The above three groups set up control groups, respectively. Western blot assay was used to check the levels of p53, phosphorylated p53 at 20 site (p53-ser20), p21, cyclin D1 and CDK4. Immunoprecipitation assay was used to investigate the roles of p53 in the interaction of p21, cyclin D1 and CDK4. RESULTS: After inhibition of p53 using PFT-alpha or siRNA, the high levels of p53, p53-ser 20 and p21 induced by B [a] P were markedly decreased. The change of cyclin D1 level was not obsevered and the level CDK4 was free of B [a] P. The combination of p21 and CDK 4 was increased after HELFs exposed to B [a] P, which can not be observed after inhibition p53. The combination of p21 and cyclin D1 was increased with or without the expression of p53 after HELFs exposed to B [a] P. The combination of cyclin D1 and CDK 4 was not affected by B [a] P. CONCLUSION: p53 can affect the combination of p21 and CDK4 in HELFs induced by B [a] P.

About this research paper

What this paper is about

OBJECTIVE: To investigate the roles of p53 in the interaction of p21, cyclin D1 and CDK4 in human embryonic lung fibroblasts (HELFs) induced by benzo (a) pyrene. METHODS: p53-H group (cells transfected with p53 small interference RNA plasmid, p53 siRNA) and HELF/CMV group (cells transfected with CMV vector) were treated with 2 micromol/L B [a] P for 24 h, and HELF/CMV + PFT-alpha group (HELF/CMV cells were treated with p53 chemical inhibitor, Pifithrin-alpha) was treated with 2 micromol/L B [a] P and 20 micromol/L PFT-alpha for 24 h. The above three groups set up control groups, respectively. Western blot assay was used to check the levels of p53, phosphorylated p53 at 20 site (p53-ser20), p21, cyclin D1 and CDK4. Immunoprecipitation assay was used to investigate the roles of p53 in the interaction of p21, cyclin D1 and CDK4. RESULTS: After inhibition of p53 using PFT-alpha or siRNA, the high levels of p53, p53-ser 20 and p21 induced by B [a] P were markedly decreased. The change of cyclin D1 level was not obsevered and the level CDK4 was free of B [a] P. The combination of p21 and CDK 4 was increased after HELFs exposed to B [a] P, which can not be observed after inhibition p53. The combination of p21 and cyclin D1 was increased with or without the expression of p53 after HELFs exposed to B [a] P. The combination of cyclin D1 and CDK 4 was not affected by B [a] P. CONCLUSION: p53 can affect the combination of p21 and CDK4 in HELFs induced by B [a] P.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To investigate the roles of p53 in the interaction of p21, cyclin D1 and CDK4 in human embryonic lung fibroblasts (HELFs) induced by benzo (a) pyrene. METHODS: p53-H group (cells transfected with p53 small interference RNA plasmid, p53 siRNA) and HELF/CMV group (cells transfected with CMV vector) were treated with 2 micromol/L B [a] P for 24 h, and HELF/CMV + PFT-alpha group (HELF/CMV cells were treated with p53 chemical inhibitor, Pifithrin-alpha) was treated with 2 micromol/L B [a] P and 20 micromol/L PFT-alpha for 24 h. The above three groups set up control groups, respectively. Western blot assay was used to check the levels of p53, phosphorylated p53 at 20 site (p53-ser20), p21, cyclin D1 and CDK4. Immunoprecipitation assay was used to investigate the roles of p53 in the interaction of p21, cyclin D1 and CDK4. RESULTS: After inhibition of p53 using PFT-alpha or siRNA, the high levels of p53, p53-ser 20 and p21 induced by B [a] P were markedly decreased. The change of cyclin D1 level was not obsevered and the level CDK4 was free of B [a] P. The combination of p21 and CDK 4 was increased after HELFs exposed to B [a] P, which can not be observed after inhibition p53. The combination of p21 and cyclin D1 was increased with or without the expression of p53 after HELFs exposed to B [a] P. The combination of cyclin D1 and CDK 4 was not affected by B [a] P. CONCLUSION: p53 can affect the combination of p21 and CDK4 in HELFs induced by B [a] P.

Key concepts: Cyclin D1, Transfection, Molecular biology, Cyclin-dependent kinase, Western blot, Biology, Cyclin E, Cyclin D

Related papers

Back to paper searchBrowse research topicsOriginal source
[Roles of p53 in the interaction of p21 and cell cycle proteins induced by benzo [a] pyrene]. — Research Paper | ScholarLens